W. Knowler, E. Barrett-connor, . Fowler, and . Se, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, vol.346, pp.393-403, 2002.

Y. Shu, . Sheardown, . Sa, and . Brown, Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action, Journal of Clinical Investigation, vol.117, issue.5, pp.1422-1431, 2007.
DOI : 10.1172/JCI30558DS1

Z. Wang, . Yin, . Oq, B. Tomlinson, and M. Chow, OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine, Pharmacogenetics and Genomics, vol.18, issue.7, pp.637-645, 2008.
DOI : 10.1097/FPC.0b013e328302cd41

K. Zhou, C. Bellenguez, and . Spencer, Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes, Nature Genetics, vol.352, issue.2, pp.117-120, 2011.
DOI : 10.1016/0014-5793(95)00172-6

A. Natali and E. Ferrannini, Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review, Diabetologia, vol.27, issue.3, pp.434-441, 2006.
DOI : 10.1007/s00125-006-0141-7

G. Zhou, R. Myers, and Y. Li, Role of AMP-activated protein kinase in mechanism of metformin action, Journal of Clinical Investigation, vol.108, issue.8, pp.1167-1174, 2001.
DOI : 10.1172/JCI13505

M. Foretz and B. Viollet, Regulation of hepatic metabolism by AMPK, Journal of Hepatology, vol.54, issue.4, pp.827-829, 2011.
DOI : 10.1016/j.jhep.2010.09.014
URL : https://hal.archives-ouvertes.fr/inserm-00555334

X. Stephenne, M. Foretz, and . Taleux, Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status, Diabetologia, vol.25, issue.12, pp.3101-3110, 2011.
DOI : 10.1007/s00125-011-2311-5

S. Hawley, . Ross, . Fa, and C. Chevtzoff, Use of Cells Expressing ?? Subunit Variants to Identify Diverse Mechanisms of AMPK Activation, Cell Metabolism, vol.11, issue.6, pp.554-565, 2010.
DOI : 10.1016/j.cmet.2010.04.001

M. Foretz, S. Hebrard, and J. Leclerc, Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state, Journal of Clinical Investigation, vol.120, issue.7, pp.2355-2369, 2010.
DOI : 10.1172/JCI40671DS1
URL : https://hal.archives-ouvertes.fr/inserm-00495746

B. Viollet, B. Guigas, S. Garcia, and N. , Cellular and molecular mechanisms of metformin: an overview, Clinical Science, vol.30, issue.6, pp.253-270, 2012.
DOI : 10.1002/mc.20637
URL : https://hal.archives-ouvertes.fr/inserm-00658070

M. Yin, . Van-der-horst, . Ic, . Van-melle, and . Jp, Metformin improves cardiac function in a non-diabetic rat model of post-MI heart failure, Am J Physiol Heart Circ Physiol, p.15, 2011.

E. Kravchuk, E. Grineva, A. Bairamov, M. Galagudza, and T. Vlasov, The Effect of Metformin on the Myocardial Tolerance to Ischemia-Reperfusion Injury in the Rat Model of Diabetes Mellitus Type II AMP-activated protein kinase activation during cardioplegia-induced hypoxia/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress, Exp Diabetes Res Mediators Inflamm, vol.20112010, pp.907496-907512, 2010.

S. Gundewar, J. Calvert, and . Jha, Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure, Circulation Research, vol.104, issue.3, pp.403-411, 2009.
DOI : 10.1161/CIRCRESAHA.108.190918

R. Roussel, F. Travert, and . Pasquet, Metformin Use and Mortality Among Patients With Diabetes and Atherothrombosis<alt-title>Metformin Use With Diabetes and Atherothrombosis</alt-title>, Archives of Internal Medicine, vol.170, issue.21, pp.1892-1899, 2010.
DOI : 10.1001/archinternmed.2010.409

B. Viollet and M. Foretz, Metformine et cancer. Du diab??te au cancer??: de nouvelles perspectives th??rapeutiques pour la metformine, M??decine des Maladies M??taboliques, vol.5, issue.1, pp.29-37, 2011.
DOI : 10.1016/S1957-2557(11)70183-3

S. Barco, A. Vazquez-martin, and . Cufi, Metformin: Multi-faceted protection against cancer, Oncotarget, vol.2, issue.12, pp.896-917, 2011.
DOI : 10.18632/oncotarget.387